ES2180781T3 - Nuevos ligandos del receptor opiaceo mu: agonistas y antagonistas. - Google Patents

Nuevos ligandos del receptor opiaceo mu: agonistas y antagonistas.

Info

Publication number
ES2180781T3
ES2180781T3 ES96919169T ES96919169T ES2180781T3 ES 2180781 T3 ES2180781 T3 ES 2180781T3 ES 96919169 T ES96919169 T ES 96919169T ES 96919169 T ES96919169 T ES 96919169T ES 2180781 T3 ES2180781 T3 ES 2180781T3
Authority
ES
Spain
Prior art keywords
trp
seq
xaa
tyr
phe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96919169T
Other languages
English (en)
Inventor
Colette T Dooley
Richard A Houghten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Torrey Pines Institute for Molecular Studies
Original Assignee
Torrey Pines Institute for Molecular Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrey Pines Institute for Molecular Studies filed Critical Torrey Pines Institute for Molecular Studies
Application granted granted Critical
Publication of ES2180781T3 publication Critical patent/ES2180781T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION APORTA NUEVOS PEPTIDOS OPIOIDES. SE DESCRIBEN PEPTIDOS OPIODES QUE TIENEN LA ESTRUCTURA GENERAL ACPHE ARG TRP TRP TYR XAA NH 2 (SEQ ID N 1); AC ARG TRP ILE GLY TRP XAA - NH 2 (SEQ ID N 2); TRP TRP PRO LYS/ARG HIS SUB,Z XAA Z - NH 2 (SEQ ID N 222); TYR PRO PHE GLY PHE XAA NH 2 (SEQ ID N 5); (D)ILE (D)MET (D)SER (D)TRP (D)TRP GLY N XAA NH 2 (SEQ ID N 6); Y (D)ILE (D)MET (D )THR (D)TRP GLY XAA NH 2 (SEQ ID N 7). DENTRO DE CADA GENERO, XAA ESTA SUSTITUIDO POR UN AMINOACIDO ESPECIFICO. LA INVENCION TAMBIEN SE REFIERE A UN PEPTIDO OPIOIDE QUE TIENE LA ESTRUCTURA GENERAL TIR-A1-B2-C3-NH 2 (SEQ ID N 8), DONDE A ES D-NVE O D-NLE, B ES GLY, PHE O TRP, Y C ES TRP O NAP. TAMBIEN SE INCLUYEN CON LA INVENCION COMPUESTOS OPIOIDES CON LA ESTRUCTURA GENERAL ME X H Y N TYR TYR PHE Z PRO Z - NH 2 (SEQ ID N 221), LOS CUALES SON PEPTIDOS MODIFICADOS POR PERMETILACION, PERALILACION, PERETILACION, PERBENCILACION O PERNAFTILACION Y QUE PUEDEN SER MODIFICADOS ADICIONALMENTE POR REDUCCION.
ES96919169T 1995-06-07 1996-06-06 Nuevos ligandos del receptor opiaceo mu: agonistas y antagonistas. Expired - Lifetime ES2180781T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47643895A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
ES2180781T3 true ES2180781T3 (es) 2003-02-16

Family

ID=23891841

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96919169T Expired - Lifetime ES2180781T3 (es) 1995-06-07 1996-06-06 Nuevos ligandos del receptor opiaceo mu: agonistas y antagonistas.

Country Status (8)

Country Link
EP (1) EP0853484B1 (es)
AT (1) ATE223927T1 (es)
AU (1) AU707245B2 (es)
CA (1) CA2223428A1 (es)
DE (1) DE69623635T2 (es)
DK (1) DK0853484T3 (es)
ES (1) ES2180781T3 (es)
WO (1) WO1996040208A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885958A (en) * 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
TW460478B (en) 1997-08-15 2001-10-21 Chugai Pharmaceutical Co Ltd Phenethylamine derivatives
US6548637B1 (en) 1998-06-18 2003-04-15 Sepracor, Inc. Ligands for opioid receptors
TW509699B (en) 1998-09-24 2002-11-11 Chugau Pharmaceutical Co Ltd Ethylamine derivatives
PL349354A1 (en) 1999-01-28 2002-07-15 Chugai Pharmaceutical Co Ltd Substituted phenethylamine derivatives
WO2001070684A2 (en) 2000-03-16 2001-09-27 Sepracor, Inc. Peptidomimetic ligands for cellular receptors and ion channels
WO2002028814A2 (en) * 2000-10-06 2002-04-11 Regents Of The University Of California Nmda receptor channel blocker with neuroprotective activity
RU2470040C2 (ru) 2006-10-17 2012-12-20 Ратджерс, Те Стейт Юниверсити Оф Нью Джерси N-замещенные мономеры и полимеры

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2090171A1 (en) * 1993-02-23 1994-08-24 Peter W. Schiller Opioid receptor antagonists, their synthesis and use as analgesic and immunosuppressive compounds
IS4261A (is) * 1994-02-21 1995-08-22 Astra Aktiebolag Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra

Also Published As

Publication number Publication date
DE69623635D1 (de) 2002-10-17
AU707245B2 (en) 1999-07-08
DE69623635T2 (de) 2003-05-08
CA2223428A1 (en) 1996-12-19
EP0853484A4 (en) 1999-11-03
AU6157696A (en) 1996-12-30
WO1996040208A1 (en) 1996-12-19
EP0853484B1 (en) 2002-09-11
EP0853484A1 (en) 1998-07-22
ATE223927T1 (de) 2002-09-15
DK0853484T3 (da) 2003-01-20

Similar Documents

Publication Publication Date Title
US5641861A (en) μopioid receptor ligands: agonists and antagonists
US5919897A (en) MU opioid receptor ligands: agonists and antagonists
US6080398A (en) Truncated gro and KC chemokines having enhanced bioactivity
HK1119955A1 (en) Modified kunitz domain polypeptide
ES2063350T3 (es) Nuevas proteinas con efecto inhibidor del tnf y su produccion.
IL128829A0 (en) Improved solid-phase peptide and agent for use in such synthesis
WO1999031255A3 (en) Novel egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes
MD1652G2 (ro) Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină
Okada et al. Structural studies of [2′, 6′-dimethyl-L-tyrosine1] endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bond
NZ333606A (en) Isolated peptides derived from MAGE-2
ES2180781T3 (es) Nuevos ligandos del receptor opiaceo mu: agonistas y antagonistas.
SK287880B6 (sk) Peptide LHRH-antagonists with improved solubility, pharmaceutical composition containing the peptides, method for the preparation of the peptides and their use and method for producing medicaments
MY104909A (en) Peptide compounds.
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
AU2865801A (en) Therapeutic peptides
Fahrenholz et al. Synthesis and biological activities of arginine-vasopressin analogues with reactive groups
Sugano et al. Studies of peptide antibiotics. XXX. Syntheses of gramicidin S analogs containing N-methylleucine in place of leucine
Higuchi et al. Dimeric substance P analogue shows a highly potent activity of the in vivo salivary secretion in the rat
AU8302791A (en) Recombinant gene coding for a protein having an endochitinase activity
YU48997A (sh) Novi biološki aktivni proteini, njihove farmaceutske smeše i postupak za njihovo dobijanje
SE9800865D0 (sv) New Process
DE69827880D1 (de) Iga1-protease fragment als trägerpeptid
AU2003229155A1 (en) Scorpion peptide as hypotensive agent
NZ509284A (en) Tumour antigen peptide derived from SART-that binds to HLA-A24 antigen thereby facilitating recognition by a T call
NZ606260A (en) Novel polypeptides involved in immune response